Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pharmacogenetics of Antidepressant-Induced Disinhibition — Stella

Home/Obsessive-Compulsive Disorder/Pharmacogenetics of Antidepressant-Induced Disinhibition

View on ClinicalTrials.gov

Recruiting

Back to Obsessive-Compulsive Disorder trials

Pharmacogenetics of Antidepressant-Induced Disinhibition

Trial locations(1 site)

Canada

Child and Adolescent Addiction, Mental Health & Psychiatry, Calgary, Alberta

Key details

Sponsor

University of Calgary

Collaborators

Hotchkiss Brain Institute, University of Calgary, Alberta Health services

Enrollment target

~120 participants

Started

January 2019

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

6 Years – 17 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.